London, United Kingdom
Korecyte Bio, a London-based cell therapy startup founded in 2023, is dedicated to advancing the field of cell therapy. The company's mission is to enhance the safety and efficacy of cell therapy for treating solid tumors and beyond. With a focus on next-generation cell therapy tools, Korecyte Bio aims to improve outcomes for cancer patients through the development of CAR-T products that can safely target a range of solid cancers.
Operating in the Biotechnology and Health and Wellness industries, Korecyte Bio is positioned at the forefront of innovative medical advancements. As of now, the company has not disclosed its latest investment details or investors, but its commitment to revolutionizing cell therapy makes it a promising candidate for potential investors interested in the biotech sector.
